| 29 Aug, 03:22 pm | — | … | Lincoln Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 11-Sep-2026. | nse |
| 29 Aug, 03:15 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Intimation Of Book Closure And Record Date For The Purpose Of 32Nd Annual General Meeting And Final Dividend For The Financial Year 2025-26. | bse |
| 29 Aug, 03:05 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Corporate Action-Fixes Book Closure For Determining The Dividend, If Approved At The AGM | bse |
| 13 Aug, 11:49 am | — | … | Lincoln Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 13 Aug, 11:46 am | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Un-Audited Financial Results For Quarter Ended On 30 June, 2026. | bse |
| 13 Aug, 11:37 am | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Outcome for Board Meeting Outcome For Un-Audited Financial Results For The Quarter Ended On June 30, 2026. | bse |
| 06 Aug, 12:37 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026. | bse |
| 29 May, 03:08 pm | — | … | Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication with respect to Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31, 2026. | nse |
| 28 May, 05:24 pm | — | … | Lincoln Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 28, 2026, recommended Final Dividend of Rs. 1.80 per equity share. | nse |
| 28 May, 05:21 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Corporate Action-Board approves Dividend | bse |
| 28 May, 05:16 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Audited Financial Results For The Quarter And Year Ended 31St March, 2026 | bse |
| 28 May, 05:09 pm | — | … | Lincoln Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 28 May, 05:09 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended 31St March, 2026. | bse |
| 18 May, 02:42 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Corporate Action-Board to consider Dividend | bse |
| 18 May, 02:36 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Intimation for Consideration Of Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Year Ended On March 31, 2026. | bse |
| 12 May, 07:28 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 05 May, 04:52 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | bse |
| 16 Apr, 02:25 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | bse |
| 08 Apr, 06:25 pm | — | … | The Exchange had sought clarification from Lincoln Pharmaceuticals Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI. The response of the Company is enclosed. | nse |
| 08 Apr, 04:01 pm | — | … | Munjal Mahendrabhai Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 08 Apr, 04:00 pm | — | … | Munjal Mahendrabhai Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 23 Feb, 11:36 am | — | … | Lincoln Pharmaceuticals Limited has informed the Exchange about Transcript of the investor meet held on February 18, 2026. | nse |
| 23 Feb, 11:33 am | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 18 Feb, 06:36 pm | — | … | Lincoln Pharmaceuticals Limited has informed the Exchange about Link of Recording for the Investor call held today. | nse |
| 18 Feb, 06:32 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 13 Feb, 05:46 pm | — | … | Lincoln Pharmaceuticals Limited has informed the Exchange about Schedule of Earnings Conference Call to discuss the unaudited financial results of the Company for the Quarter and Nine months ended December-2025. | nse |
| 12 Feb, 11:38 am | — | … | Lincoln Pharmaceuticals Ltd - 531633 - UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED ON 31.12.2025 | bse |
| 12 Feb, 11:30 am | — | … | Lincoln Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | nse |
| 12 Feb, 11:29 am | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Outcome for OUTCOME OF BOARD MEETING | bse |
| 04 Feb, 12:07 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Third Quarter And Nine Months Ended 31St December, 2025. | bse |
| 10 Jan, 04:52 pm | — | … | Lincoln Pharmaceuticals Limited has informed the Exchange about Credit Rating | nse |
| 10 Jan, 04:46 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Announcement under Regulation 30 (LODR)-Credit Rating | bse |
| 07 Jan, 05:52 pm | — | … | The Exchange has sought clarification from Lincoln Pharmaceuticals Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited. | nse |
| 14 Nov, 02:43 pm | — | … | Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication with respect to unaudited financial results of the company for the quarter and half year ended on 30.09.2025. | nse |
| 13 Nov, 12:33 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025 | bse |
| 13 Nov, 12:32 pm | — | … | Lincoln Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. | nse |
| 13 Nov, 12:28 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Outcome for UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025 | bse |
| 05 Nov, 03:04 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter And Half Year Ended 30.09.2025. | bse |
| 06 Sept, 04:21 pm | — | … | Lincoln Pharmaceuticals Limited has informed the Exchange about Intimation regarding dispatch of physical communication to the Shareholders who have not registered their email address. | nse |
| 06 Sept, 04:16 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - General Updates | bse |
| 06 Sept, 03:13 pm | — | … | Lincoln Pharmaceuticals Ltd - 531633 - Reg. 34 (1) Annual Report. | bse |